Serum Adiponectin Level in Diabetic Patients with and Without Helicobacter Pylori Infection: is There Any Difference?

Overview

Journal ScientificWorldJournal

Publisher Wiley

Specialty Biology

Date 2014 Feb 14

PMID 24523637

Citations 4

Authors

Jamshid Vafaeimanesh

Akram Heidari

Marzieh Effatpanah

Mahmoud Parham

Affiliations

Soon will be listed here.

Abstract

Background: Increased insulin resistance is an extragastrointestinal manifestation of Helicobacter pylori (HP) infection. HP changes the level of inflammatory markers and cytokines and changes the adipocyte function by altering the adiponectin level. Given the high prevalence of HP and diabetes in our society, we evaluated the association between HP and serum adiponectin level. In this cross-sectional study, 211 diabetic patients under treatment other than insulin were studied. These patients were divided into two groups of HP+ and HP- based on their HP IgG antibody serology and their blood adiponectin levels were measured. Data was analyzed using independent t-test, Chi-square test, and Fisher's exact test.

Results: Seventy-two patients with an average age of 51.56 ± 8.34 years were HP- and 139 patients with an average age of 50.35 ± 9.01 years were HP+. The mean serum adiponectin level in HP- and HP+ groups was 4.54 ± 5.43 and 5.64 ± 3.88 ng/mL, respectively. Insulin resistance degree was significantly higher in HP+ group (HP- = 3.160 ± 3.327 versus HP+ = 4.484 ± 3.781, P = 0.013) but no significant difference was found between the mean serum adiponectin level in HP- and HP+ groups (P = 0.140).

Conclusions: Although the insulin resistance degree was significantly higher in HP+ diabetic patients, no significant relationship was found between HP infection and serum levels of adiponectin.

Citing Articles

Effects of hydroalcoholic extract of seed on glucose and insulin related biomarkers, lipid profile, and hepatic enzymes in nicotinamide-streptozotocin-induced type II diabetic male mice.

Ahangarpour A, Heidari H, Junghani M, Absari R, Khoogar M, Ghaedi E Res Pharm Sci. 2017; 12(5):416-424.

PMID: 28974980 PMC: 5615872. DOI: 10.4103/1735-5362.213987.

H. pylori seroprevalence and risk of diabetes: An ancillary case-control study nested in the diabetes prevention program.

AlZahrani S, Nelson J, Moss S, Paulus J, Knowler W, Pittas A J Diabetes Complications. 2017; 31(10):1515-1520.

PMID: 28739267 PMC: 5603174. DOI: 10.1016/j.jdiacomp.2017.05.015.

Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics?.

Vafaeimanesh J, Parham M, Bagherzadeh M Indian J Endocrinol Metab. 2015; 19(3):364-8.

PMID: 25932391 PMC: 4366774. DOI: 10.4103/2230-8210.152773.

Association of Helicobacter pylori infection with glycemic control in patients with diabetes: a meta-analysis.

Horikawa C, Kodama S, Fujihara K, Yachi Y, Tanaka S, Suzuki A J Diabetes Res. 2014; 2014:250620.

PMID: 24901007 PMC: 4034768. DOI: 10.1155/2014/250620.

References

Zhou X, Zhang C, Wu J, Zhang G . Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies. Diabetes Res Clin Pract. 2013; 99(2):200-8. DOI: 10.1016/j.diabres.2012.11.012. View

Rothenbacher D, Brenner H . Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: recent developments and future implications. Microbes Infect. 2003; 5(8):693-703. DOI: 10.1016/s1286-4579(03)00111-4. View

Renaldi O, Pramono B, Sinorita H, Purnomo L, Asdie R, Asdie A . Hypoadiponectinemia: a risk factor for metabolic syndrome. Acta Med Indones. 2009; 41(1):20-4. View

Bloomgarden Z . Measures of insulin sensitivity. Clin Lab Med. 2006; 26(3):611-33, vi. DOI: 10.1016/j.cll.2006.06.007. View

Lin Y, Chiang J, Lin S, Tseng C . Helicobacter pylori infection concomitant with metabolic syndrome further increase risk of colorectal adenomas. World J Gastroenterol. 2010; 16(30):3841-6. PMC: 2921097. DOI: 10.3748/wjg.v16.i30.3841. View

Gillum R . Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc. 2004; 96(11):1470-6. PMC: 2568603. View

Ostrowska L, Fiedorczuk J, Adamska E . Effect of diet and other factors on serum adiponectin concentrations in patients with type 2 diabetes. Rocz Panstw Zakl Hig. 2013; 64(1):61-6. View

So W, Tong P, Ko G, Ma R, Ozaki R, Kong A . Low plasma adiponectin level, white blood cell count and Helicobacter pylori titre independently predict abnormal pancreatic beta-cell function. Diabetes Res Clin Pract. 2009; 86(2):89-95. DOI: 10.1016/j.diabres.2009.08.010. View

Lihn A, Pedersen S, Richelsen B . Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev. 2005; 6(1):13-21. DOI: 10.1111/j.1467-789X.2005.00159.x. View

10.

Tang C, Chiu Y, Tan T, Yang R, Fu W . Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol. 2007; 179(8):5483-92. DOI: 10.4049/jimmunol.179.8.5483. View

11.

Gen R, Demir M, Ataseven H . Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J. 2010; 103(3):190-6. DOI: 10.1097/SMJ.0b013e3181cf373f. View

12.

Naja F, Nasreddine L, Hwalla N, Moghames P, Shoaib H, Fatfat M . Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter. 2012; 17(6):444-51. DOI: 10.1111/j.1523-5378.2012.00970.x. View

13.

Ando T, Ishikawa T, Takagi T, Imamoto E, Kishimoto E, Okajima A . Impact of Helicobacter pylori eradication on circulating adiponectin in humans. Helicobacter. 2012; 18(2):158-64. DOI: 10.1111/hel.12028. View

14.

Aslan M, Horoz M, Nazligul Y, Bolukbas C, Bolukbas F, Selek S . Insulin resistance in H pylori infection and its association with oxidative stress. World J Gastroenterol. 2006; 12(42):6865-8. PMC: 4087444. DOI: 10.3748/wjg.v12.i42.6865. View

15.

Diez J, Iglesias P . The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003; 148(3):293-300. DOI: 10.1530/eje.0.1480293. View

16.

Aydemir S, Bayraktaroglu T, Sert M, Sokmen C, Atmaca H, Mungan G . The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci. 2005; 50(11):2090-3. DOI: 10.1007/s10620-005-3012-z. View

17.

Eshraghian A, Hashemi S, Hamidian Jahromi A, Eshraghian H, Masoompour S, Davarpanah M . Helicobacter pylori infection as a risk factor for insulin resistance. Dig Dis Sci. 2008; 54(9):1966-70. DOI: 10.1007/s10620-008-0557-7. View

18.

Hainer V, Aldhoon Hainerova I, Zamrazilova H . [Role of infection in the pathogenesis of obesity]. Cas Lek Cesk. 2013; 151(12):563-7. View

19.

Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O . Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction. Diabetes Metab Syndr Obes. 2013; 6:293-301. PMC: 3746783. DOI: 10.2147/DMSO.S46627. View

20.

Hung J, McQuillan B, Thompson P, Beilby J . Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes (Lond). 2008; 32(5):772-9. DOI: 10.1038/sj.ijo.0803793. View